Sanofi finishes buyout of Genzyme

04/10/2011 | Reuters

Sanofi-Aventis finalized a deal worth about $20.1 billion to take over Genzyme. The acquisition, which gives Sanofi access to Genzyme's orphan-drug business, will be partly funded through a $7 billion note offering.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ